drugset / Trial / NCT00460213
Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to compare improvement percentage of urinary albumin excretion between valsartan 80 mg- and valsartan 160 mg-based therapy in patient with morning hypertension.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-12
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valsartan | Small molecule | 80 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |
| Subject | Valsartan | Small molecule | — | — |